FDA grapples with ‘Wild West’ CBD market

SNL Image

Cannabidiol is appearing in all kinds of consumer products as the U.S. Food and Drug Administration struggles to come up with guidelines for regulating substance.
These gummy worms displayed at the Cannabis World Congress Business Exposition trade show in May contain 10 milligrams of CBD.

Source: The Associated Press

During a 10-hour, jam-packed public hearing, top officials from the U.S. Food and Drug Administration said the agency is unsure how to rein in the cannabis market’s newest fad: cannabidiol.

Acting FDA Commissioner Ned Sharpless explained during the May 31 hearing that in response to the growing cannabidiol market, the agency is establishing a working group to increase its knowledge of CBD and address unanswered safety concerns regarding the consumption of CBD products.

While the FDA is still grappling with some of the finer points of CBD regulation, the agency is adamant about

... read more at: https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/52316516